Roivant Sciences Ltd. - Investor Relations & Filings
Key figures FY2026
| Total Revenues | USD 8.26k | per the Annual Report filed 2026-05-20 |
|---|---|---|
| Net Income | USD -397.91k | per the Annual Report filed 2026-05-20 |
| Total Assets | USD 5.71M | per the Annual Report filed 2026-05-20 |
| Total Equity | USD 5.29M | per the Annual Report filed 2026-05-20 |
| Cash from Ops | USD -750.35k | per the Annual Report filed 2026-05-20 |
As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.
Roivant Sciences is a biopharmaceutical company that develops and commercializes medicines and technologies. The company operates a unique model by building agile, focused subsidiary companies known as 'Vants' to advance specific assets. This structure is designed to accelerate the discovery, development, and delivery of innovative treatments to patients through efficient capital allocation and execution. Roivant employs technology, including artificial intelligence for drug discovery and protein design, across its operations. The company's portfolio spans multiple therapeutic areas, such as autoimmune and pulmonary diseases, and includes commercial-stage products like Vtama for psoriasis and atopic dermatitis, alongside a broad pipeline of investigational drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - ROIVANT SCIENCES LTD. (0001635088) (Filer) | 2026-02-24 | English | |
| 4 - ROIVANT SCIENCES LTD. (0001635088) (Filer) | 2026-02-18 | English | |
| 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-02-14 | English | |
| 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-02-14 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| 4 Filing | 2026-02-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 32895555 | 4 - ROIVANT SCIENCES LTD. (0001635088) (Filer) | 2026-02-24 | English | ||
| 32895556 | 4 - ROIVANT SCIENCES LTD. (0001635088) (Filer) | 2026-02-18 | English | ||
| 19636081 | 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-02-14 | English | ||
| 19635459 | 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-02-14 | English | ||
| 31034204 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31034155 | 4 Filing | 2026-02-13 | English | ||
| 31034167 | 4 Filing | 2026-02-11 | English | ||
| 31034291 | 10-Q Filing | 2026-02-06 | English | ||
| 31034113 | 8-K Filing | 2026-02-06 | English | ||
| 31034234 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 31034232 | 4 Filing | 2026-01-22 | English | ||
| 31034209 | 4 Filing | 2026-01-22 | English | ||
| 31034107 | 4 Filing | 2026-01-22 | English | ||
| 12856055 | FORM 4 | 2026-01-15 | English | ||
| 12856058 | Regulatory Filings 2026 | 2026-01-12 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Roivant Sciences Ltd., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available - coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
| 4D Pharma PLC | DDDD | GB | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
Roivant Sciences Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30587/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30587 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing - metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30587 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30587 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30587}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Roivant Sciences Ltd. (id: 30587)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.